N-(5-Carbamoyl-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)phenyl)-3,4-dichlorobenzamide

ID: ALA3612132

Chembl Id: CHEMBL3612132

PubChem CID: 122187967

Max Phase: Preclinical

Molecular Formula: C26H18Cl2N4O4

Molecular Weight: 521.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc(NC(=O)c2ccc(-n3ccccc3=O)cc2)c(NC(=O)c2ccc(Cl)c(Cl)c2)c1

Standard InChI:  InChI=1S/C26H18Cl2N4O4/c27-19-10-6-17(13-20(19)28)26(36)31-22-14-16(24(29)34)7-11-21(22)30-25(35)15-4-8-18(9-5-15)32-12-2-1-3-23(32)33/h1-14H,(H2,29,34)(H,30,35)(H,31,36)

Standard InChI Key:  FNCSYBJEPMIBLB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3612132

    ---

Associated Targets(Human)

F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.36Molecular Weight (Monoisotopic): 520.0705AlogP: 4.75#Rotatable Bonds: 6
Polar Surface Area: 123.29Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.71CX Basic pKa: CX LogP: 4.14CX LogD: 4.14
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.34Np Likeness Score: -1.52

References

1. Yang J, Su G, Ren Y, Chen Y..  (2015)  Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.,  101  [PMID:26114810] [10.1016/j.ejmech.2015.06.012]

Source